Phase 2 Epidermolysis Bullosa Simplex Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
Generalized Epidermolysis Bullosa Simplex
TWi Biotechnology, Inc.80 enrolled36 locationsNCT06073132
Recruiting
Phase 2
A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
Epidermolysis Bullosa Simplex
BioMendics, LLC40 enrolled2 locationsNCT07027345
Recruiting
Phase 2
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
IchthyosisEpidermolysis Bullosa SimplexGenodermatosis+1 more
Centre Hospitalier Universitaire de Nice10 enrolled2 locationsNCT06136403
Recruiting
Phase 2
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
Epidermolysis Bullosa SimplexGenodermatosis
Centre Hospitalier Universitaire de Nice20 enrolled4 locationsNCT06509984